NO166383C - Fremgangsmaate ved fremstilling av bispesifikke antistoff-determinanter. - Google Patents

Fremgangsmaate ved fremstilling av bispesifikke antistoff-determinanter.

Info

Publication number
NO166383C
NO166383C NO85855200A NO855200A NO166383C NO 166383 C NO166383 C NO 166383C NO 85855200 A NO85855200 A NO 85855200A NO 855200 A NO855200 A NO 855200A NO 166383 C NO166383 C NO 166383C
Authority
NO
Norway
Prior art keywords
molecules
antibody determinants
determinant
bispecific antibody
procedure
Prior art date
Application number
NO85855200A
Other languages
English (en)
Norwegian (no)
Other versions
NO166383B (no
NO855200L (no
Inventor
Henry P Paulus
Original Assignee
Boston Biomed Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston Biomed Res Inst filed Critical Boston Biomed Res Inst
Publication of NO855200L publication Critical patent/NO855200L/no
Publication of NO166383B publication Critical patent/NO166383B/no
Publication of NO166383C publication Critical patent/NO166383C/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO85855200A 1984-04-23 1985-12-20 Fremgangsmaate ved fremstilling av bispesifikke antistoff-determinanter. NO166383C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60312584A 1984-04-23 1984-04-23
PCT/US1985/000737 WO1985004811A1 (en) 1984-04-23 1985-04-22 Bispecific antibody determinants

Publications (3)

Publication Number Publication Date
NO855200L NO855200L (no) 1985-12-20
NO166383B NO166383B (no) 1991-04-02
NO166383C true NO166383C (no) 1991-07-10

Family

ID=24414191

Family Applications (1)

Application Number Title Priority Date Filing Date
NO85855200A NO166383C (no) 1984-04-23 1985-12-20 Fremgangsmaate ved fremstilling av bispesifikke antistoff-determinanter.

Country Status (11)

Country Link
EP (1) EP0179872B1 (de)
JP (1) JPH0617909B2 (de)
AT (1) ATE64622T1 (de)
AU (1) AU595159B2 (de)
CA (1) CA1338828C (de)
DE (1) DE3583278D1 (de)
DK (1) DK169153B1 (de)
FI (1) FI85946C (de)
IT (1) IT1183798B (de)
NO (1) NO166383C (de)
WO (1) WO1985004811A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987004164A1 (en) * 1986-01-06 1987-07-16 The University Of Melbourne Technetium-antibody conjugate
FR2604092B1 (fr) * 1986-09-19 1990-04-13 Immunotech Sa Immunoreactifs destines a cibler les cellules animales pour leur visualisation ou leur destruction in vivo
FR2608445B1 (fr) * 1986-12-19 1989-04-21 Muraour Renaud Embout pour manche de raquette de tennis et autres similaires, et raquette equipee de cet embout
EP0301333A3 (de) * 1987-07-29 1992-07-01 Abbott Laboratories Auf liposomen basierter, homogener Immunoassay für diagnostische Teste
US4971916A (en) * 1987-07-29 1990-11-20 Abbott Laboratories Liposome based homogeneous immunoassay for diagnostic tests
US5086002A (en) * 1987-09-07 1992-02-04 Agen Biomedical, Ltd. Erythrocyte agglutination assay
OA08953A (fr) * 1987-09-17 1990-11-30 Agen Ltd Agglutination assay
FI105320B (fi) * 1988-04-04 2000-07-31 Oncogen Menetelmä vasta-aineheterokonjugaattien valmistamiseksi, joita käytetään imusoluaktiivisuuden säätelyssä ja diagnoosissa
US6010902A (en) * 1988-04-04 2000-01-04 Bristol-Meyers Squibb Company Antibody heteroconjugates and bispecific antibodies for use in regulation of lymphocyte activity
SE8804074D0 (sv) * 1988-11-10 1988-11-10 Pharmacia Ab Sensorenhet och dess anvaendning i biosensorsystem
IT1235349B (it) * 1988-12-23 1992-06-30 Biodata Spa Saggio immunologico per determinazioni in fase omogenea
US5583003A (en) * 1989-09-25 1996-12-10 Agen Limited Agglutination assay
TW212184B (de) * 1990-04-02 1993-09-01 Takeda Pharm Industry Co Ltd
ES2583079T3 (es) * 2006-09-21 2016-09-19 Nestec S.A. Matrices a base de anticuerpos para detectar transductores de señales múltiples en células de rara circulación

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4233402A (en) * 1978-04-05 1980-11-11 Syva Company Reagents and method employing channeling
AU531777B2 (en) * 1978-04-05 1983-09-08 Syva Co. Label/solid conjugate immunoassay system
US4474893A (en) * 1981-07-01 1984-10-02 The University of Texas System Cancer Center Recombinant monoclonal antibodies
US4433859A (en) * 1981-07-16 1984-02-28 Nl Industries, Inc. Wellhead connector with release mechanism
US4433059A (en) * 1981-09-08 1984-02-21 Ortho Diagnostic Systems Inc. Double antibody conjugate
US4520110A (en) * 1981-10-06 1985-05-28 The Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing a phycobiliprotein labeled ligand or receptor
EP0076695B1 (de) * 1981-10-06 1985-02-20 The Board Of Trustees Of The Leland Stanford Junior University Fluoreszierende Konjugate zum Analysieren von Molekülen und Zellen
ES8504461A1 (es) * 1982-04-12 1985-04-16 Hybritech Inc Un procedimiento para obtener un polidoma.
CA1194415A (en) * 1982-05-05 1985-10-01 E. I. Du Pont De Nemours And Company Immunoglobulin half-molecules and process for producing hybrid antibodies
US4470925A (en) * 1982-05-05 1984-09-11 E. I. Du Pont De Nemours And Company Immunoglobulin half-molecules and process for producing hybrid antibodies
US4446233A (en) * 1982-05-05 1984-05-01 E. I. Du Pont De Nemours And Company Homogeneous immunoassay using covalent hybrid antibodies

Also Published As

Publication number Publication date
NO166383B (no) 1991-04-02
EP0179872A1 (de) 1986-05-07
EP0179872A4 (de) 1988-12-22
EP0179872B1 (de) 1991-06-19
CA1338828C (en) 1997-01-07
JPS61501418A (ja) 1986-07-10
DK601985A (da) 1985-12-23
IT1183798B (it) 1987-10-22
WO1985004811A1 (en) 1985-11-07
DK601985D0 (da) 1985-12-23
NO855200L (no) 1985-12-20
IT8567383A0 (it) 1985-04-23
DE3583278D1 (de) 1991-07-25
FI85946B (fi) 1992-03-13
ATE64622T1 (de) 1991-07-15
DK169153B1 (da) 1994-08-29
IT8567383A1 (it) 1986-10-23
AU595159B2 (en) 1990-03-29
JPH0617909B2 (ja) 1994-03-09
FI85946C (fi) 1992-06-25
AU4290185A (en) 1985-11-15
FI855086L (fi) 1985-12-19
FI855086A0 (fi) 1985-12-19

Similar Documents

Publication Publication Date Title
NO166383C (no) Fremgangsmaate ved fremstilling av bispesifikke antistoff-determinanter.
NO832989L (no) Bispesifikke antistoff-determinanter.
FI954347L (fi) Monoklonaaliset vasta-ainekoostumukset ja monoklonaalisia vasta-aineita tuottavat hybridomat
ES8101384A1 (es) Procedimiento de preparacion de productos citotoxicos
NO20004946D0 (no) Humanisert antistoff mot human vevsfaktor (TF) og fremgangsmÕte ved fremstilling av det humaniserte antistoff
SE8300290D0 (sv) Process for the production of human mono-clonal antibodies
DE122004000007I1 (de) Monoklonaler Antikörper gegen ein Cytotoxin, denselben erzeugendes Hybridoma und Verfahren für die Herstellung des gereinigten Cytotoxin.
BR8605767A (pt) Processo para producao de um artigo envolvente,artigo,e cabo do tubo ou emenda ou junta vedados pelo dito artigo
DE68913402D1 (de) Antikörper mit hoher Affinität für Methamphetamine sowie geeignetes Immunogen für seine Herstellung.
FI853283A7 (fi) Uudet monoklonaaliset glykokonjugaattien vasta-aineet, menetelmät niiden tuottamiseksi, ja niiden käytöt.
ES527290A0 (es) Procedimiento para la obtencion de frasquitos tubulares y ampollas
DE3581288D1 (de) Antileishmania monoklonale antikoerper, diese antikoerper ausscheidende hybridomas, von diesen antikoerpern erkannte leishmaniaantigene, verfahren zur herstellung und verwendung von diesen monoklonalen antikoerpern und antigenen.
IT8449292A0 (it) Linfochina,anticorpo monoclonale specifico per tale linfochina,e procedimento per la loro produzione
NZ221065A (en) Conjugates of antibodies and toxins with sulphur-containing linking groups
DE69430031D1 (de) Immunologische Bestimmungsmethode für eine Pyrethroidverbindung, Haptenverbindung, Zwischenstufe für die Haptenverbindung, Immunogen und Antikörper
EP0287397A3 (en) Monoclonal antibody specific to human pancreatic phospholipase a2
FI832765A7 (fi) Laipoitettu, muovilla vuorattu putki ja sen valmistusmenetelmä.
NO883854D0 (no) Monoklonalt antistoff og fremgangsmaate for dets fremstilling.
DE3162471D1 (en) Optical waveguide preform and process for the manufacture thereof
FI91976C (fi) Menetelmä ja reagenssi follikkelia stimuloivan hormonin määrittämiseksi sekä tähän tarkoitukseen sopivat monoklonaaliset vasta-aineet
FI882427L (fi) Saett att framstaella ett borstelement med plaststomme.
EP0255367A3 (de) Krebszellen spezifische monoklonale Antikörpern und entsprechende Hybridomas, ihre Herstellung und Anwendung
IL99222A0 (en) Monoclonal antibodies to leptosphaeria
AU7485987A (en) Method for producing monoclonal antibodies to an immunogenic antibody-antigen conjunction
FI893427A7 (fi) Monoklonaalinen vasta-aine, joka pystyy tunnistamaan gangliosideja GQ1b ja GT1a, sitä tuottava hybridooma sekä menetelmä hybridooman valmistamiseksi